Literature DB >> 23606626

Effect of assay measurement error on parameter estimation in concentration-QTc interval modeling.

Peter L Bonate1.   

Abstract

Linear mixed-effects models (LMEMs) of concentration-double-delta QTc intervals (QTc intervals corrected for placebo and baseline effects) assume that the concentration measurement error is negligible, which is an incorrect assumption. Previous studies have shown in linear models that independent variable error can attenuate the slope estimate with a corresponding increase in the intercept. Monte Carlo simulation was used to examine the impact of assay measurement error (AME) on the parameter estimates of an LMEM and nonlinear MEM (NMEM) concentration-ddQTc interval model from a 'typical' thorough QT study. For the LMEM, the type I error rate was unaffected by assay measurement error. Significant slope attenuation ( > 10%) occurred when the AME exceeded > 40% independent of the sample size. Increasing AME also decreased the between-subject variance of the slope, increased the residual variance, and had no effect on the between-subject variance of the intercept. For a typical analytical assay having an assay measurement error of less than 15%, the relative bias in the estimates of the model parameters and variance components was less than 15% in all cases. The NMEM appeared to be more robust to AME error as most parameters were unaffected by measurement error. Monte Carlo simulation was then used to determine whether the simulation-extrapolation method of parameter bias correction could be applied to cases of large AME in LMEMs. For analytical assays with large AME ( > 30%), the simulation-extrapolation method could correct biased model parameter estimates to near-unbiased levels.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23606626     DOI: 10.1002/pst.1567

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  7 in total

Review 1.  Scientific white paper on concentration-QTc modeling.

Authors:  Christine Garnett; Peter L Bonate; Qianyu Dang; Georg Ferber; Dalong Huang; Jiang Liu; Devan Mehrotra; Steve Riley; Philip Sager; Christoffer Tornoe; Yaning Wang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-12-05       Impact factor: 2.745

2.  Simulation-extrapolation method to address errors in atomic bomb survivor dosimetry on solid cancer and leukaemia mortality risk estimates, 1950-2003.

Authors:  Rodrigue S Allodji; Boris Schwartz; Ibrahima Diallo; Césaire Agbovon; Dominique Laurier; Florent de Vathaire
Journal:  Radiat Environ Biophys       Date:  2015-04-18       Impact factor: 1.925

3.  Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods.

Authors:  Jingtao Lu; Jianguo Li; Gabriel Helmlinger; Nidal Al-Huniti
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-03-19       Impact factor: 2.745

Review 4.  The role of concentration-effect relationships in the assessment of QTc interval prolongation.

Authors:  Nicholas P France; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

5.  Concentration-QT analysis of the randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.

Authors:  Rashmi Mehta; Michelle Green; Bela Patel; Jonathan Wagg
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-01-06       Impact factor: 2.745

6.  Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts.

Authors:  Aksana Jones; Jay Saini; Belinda Kriel; Laura E Via; Yin Cai; Devon Allies; Debra Hanna; David Hermann; Andre G Loxton; Gerhard Walzl; Andreas H Diacon; Klaus Romero; Ryo Higashiyama; Yongge Liu; Alexander Berg
Journal:  BMC Infect Dis       Date:  2022-04-02       Impact factor: 3.090

7.  Evaluating the Use of Linear Mixed-Effect Models for Inference of the Concentration-QTc Slope Estimate as a Surrogate for a Biological QTc Model.

Authors:  Y Huh; M M Hutmacher
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.